Incannex Healthcare Limited Common Stock
Follow $IXHL
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $IXHL by emailVeridion Score
BETALOW CONF · 4 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is IXHL moving today?
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
IXHL overview
Related filings and maps
Congress activity in IXHL
No receipt-qualified Congressional disclosure is present for IXHL in the cached public ledger.
IXHL contract awards, year to date.
Public federal awards linked to this ticker.
IXHL lobbying filings, year to date.
Registered lobbying filings matched to Incannex Healthcare Limited Common Stock.
FORBES-TATE